CVS - CVS Health Corporation
| Previous close | 76.05 |
| Open | 76.11 |
| Bid | 75.99 x 800 |
| Ask | 76.10 x 1400 |
| Day's range | 75.83 - 76.44 |
| 52-week range | 51.72 - 77.03 |
| Volume | 5,123,530 |
| Avg. volume | 6,584,901 |
| Market cap | 98.899B |
| Beta (5Y monthly) | 0.87 |
| PE ratio (TTM) | 21.41 |
| EPS (TTM) | 3.55 |
| Earnings date | 11 Feb 2020 |
| Forward dividend & yield | 2.00 (2.63%) |
| Ex-dividend date | 20 Jan 2020 |
| 1y target est | 81.67 |
- Simply Wall St.
Should CVS Health Corporation (NYSE:CVS) Be Part Of Your Dividend Portfolio?
Dividend paying stocks like CVS Health Corporation (NYSE:CVS) tend to be popular with investors, and for good reason...
- Zacks
Why CVS Health (CVS) Could Beat Earnings Estimates Again
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Zacks
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
The Zacks Analyst Blog Highlights: UnitedHealth, CVS Health, Morgan Stanley, Charles Schwab and Uber Technologies
- Zacks
CVS Health's Selling Seasons Strong, Omnicare Arm Upsets
CVS Health's (CVS) 2020 PBM selling season remains strong with gross new business and net new business wins.
- Zacks
CVS Health (CVS) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, CVS Health (CVS) closed at $72.76, marking a +0.9% move from the previous day.
- Zacks
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
Top Research Reports for UnitedHealth, CVS & Morgan Stanley
- Yahoo Finance
Cigna-Express Scripts bets on digital care as the future of health
Cigna-ESI remain focused on virtual care in 2020.
- Yahoo Finance
SmileDirectClub invades 3,800 Walmart stores with these new products
SmileDirectClub scores a big deal with Walmart.
- Simply Wall St.
CVS Health Corporation (NYSE:CVS) Might Not Be A Great Investment
Today we'll evaluate CVS Health Corporation (NYSE:CVS) to determine whether it could have potential as an investment...
- Zacks
CVS Health (CVS) Gains As Market Dips: What You Should Know
In the latest trading session, CVS Health (CVS) closed at $74.51, marking a +0.17% move from the previous day.
- Zacks
Rite Aid (RAD) Earnings Surpass Estimates in Q3, Stock Up
Rite Aid (RAD) posts robust results in third-quarter fiscal 2020. Notably, the bottom line benefits from higher adjusted EBITDA in the quarter.
- Investing.com
Breaking: Justice Dept. Sues CVS Over Medicare Prescriptions
Investing.com - The U.S. federal government filed a lawsuit against CVS Health (NYSE:CVS) and the company’s Omnicare unit Tuesday for fraudulently billing Medicare, sending shares lower.
- Zacks
Walgreens is the Worst Dow Stock Now, Will 2020 Be Different?
Despite the dismal performance in recent times, Walgreens (WBA) has chances to bounce back in 2020.
- Zacks
HMO Industry Outlook: Multiple Levers to Drive Growth
HMO Industry Outlook: Multiple Levers to Drive Growth
- Yahoo Finance
Target CEO: We are taking 'enormous' market share in cosmetics
Target CEO Brian Cornell talks with Yahoo Finance about the company's success down the cosmetics aisle.
- Zacks
CVS Health Rides on Aetna Prospects, Strong Selling Season
CVS Health's (CVS) 2020 PBM selling season is approaching closure and the 2021 selling season is ongoing.
- Zacks
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
The Zacks Analyst Blog Highlights: Toyota, CVS, 3M, Gilead and Goldman
- Zacks
UnitedHealth (UNH) to Buy Diplomat, Expand Pharmacy Services
UnitedHealth (UNH) inks an agreement to acquire Diplomat to expand its in-house pharmacy benefit management business.
- Simply Wall St.
Does CVS Health Corporation's (NYSE:CVS) P/E Ratio Signal A Buying Opportunity?
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll look at...
- Zacks
Why Is CVS Health (CVS) Up 3.8% Since Last Earnings Report?
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Yahoo Finance
20 businesses that died in the 2010s
Yahoo Finance takes a look back at some of the biggest corporate busts of the last decade.
- Bloomberg
Elizabeth Warren Wants to Spoil the Megamerger Party
(Bloomberg Opinion) -- The merger floodgates broke open five years ago, and now U.S. Senator Elizabeth Warren wants to close the hatch. Her proposed bill to substantially restrict big corporate tie-ups is more a presidential campaign statement than viable legislation — and it certainly won’t score her any more points with the Wall Street crowd — but she is calling attention to the maniacal pace of dealmaking in corporate America and the need to modernize antitrust laws that have permitted some recent problematic transactions.More than $7 trillion of takeovers of U.S. companies have been announced since this day in 2014 — 52,694 companies to be exact.(1) That compares with just $4.4 trillion of deals in the previous five-year period. The transactions grew over time as balance sheets flush with cash and income statements desperate for growth created a perfect storm, which more often than not was stoked by pliable regulators. The Walt Disney Co. acquired 21st Century Fox Inc.; Charter Communications Inc. bought Time Warner Cable Inc.; CVS Health Corp. took over Aetna Inc.; Marriott International Inc. merged with Starwood Hotels & Resorts Worldwide Inc.; and T-Mobile US Inc. is trying to buy Sprint Corp. Those are just some of the more recognizable names. Warren, one of the top-polling candidates heading into the Democratic primaries, wants to ban deals in which one company has annual revenue of more than $40 billion, or both businesses generate more than $15 billion in sales, according to a draft of the bill reviewed by Bloomberg News. (A notable exception would be companies facing insolvency.) That could effectively prevent every top airline, insurer, manufacturer, oil producer, retailer, technology platform and other conglomerates — perhaps even Warren Buffett’s M&A vehicle, Berkshire Hathaway Inc. — from making any acquisitions. It would sound the M&A death knell. The idea, however, is unlikely to gain broad support among lawmakers.Even so, it’s hard not to notice the rising drumbeat of politicians concerned about overreach by corporate giants, particularly those in the tech field. Senator Amy Klobuchar, another Democratic presidential candidate, plans to introduce separate antitrust legislation soon, Bloomberg News reported, citing a person familiar with the matter. (Michael Bloomberg, the founder and majority owner of Bloomberg LP, the parent of Bloomberg News and Bloomberg Opinion, is also campaigning for president.)For the Trump administration’s part, the U.S. Justice Department is already investigating whether tech giants — namely Apple Inc., Amazon.com Inc., Facebook Inc. and Google — are using their unchecked power to engage in harmful business practices. But as I wrote in July, if regulators are so concerned about protecting consumers from tech overreach, their glowing endorsement of T-Mobile’s takeover of Sprint is a funny way of showing it; it will shrink the U.S. wireless market from four to three major carriers and remove a company that’s helped to keep customer prices in check.Antitrust regulation under President Donald Trump has at times created questionable optics. Makan Delrahim, the Justice Department’s top antitrust enforcer, seemed to switch his stance on AT&T Inc.’s takeover of Time Warner Inc. as Trump railed against the deal. Time Warner was the parent of CNN, which Trump views as his personal nemesis. (I’ve argued that whatever the case, scrutiny of the megamerger was warranted considering the broad market power it gave to AT&T as media companies without such scale struggle to compete.) By comparison, Disney and Fox, which was controlled by Trump pal Rupert Murdoch, closed their megadeal with few regulatory hiccups. Warren has criticized other giant deals, such as the merger of SunTrust Banks Inc. and BB&T Corp. and the combination of seed makers Bayer AG and Monsanto Co. Given that they aren’t household names, though, most Americans are unfazed by or unaware of such deals, even though they may feel the effects later. Her bill would direct the government to take into account not just whether a merger will lead to higher prices but also what the impact might be on workers, privacy and industry innovation. To justify the cost of buying another large company, dealmakers tend to come up with ambitious estimates of synergies, a euphemism for layoffs. It’s clear that the meaning of “harm” needs to be expanded in the antitrust sense, and laws need to take a more holistic view of the potential consequences of M&A as the lines between industries continue to blur. The Big Tech factor also needs to be weighed, as some deals are being done in part to respond to companies like Amazon that are spreading their tentacles into new areas. On Wednesday, TV-network operators CBS Corp. and Viacom Inc. completed their own merger, a bid to cut costs and create more scale to compete against a new roster of even more powerful media giants: Amazon, Apple, AT&T and Disney. Even then, ViacomCBS Inc., as the merged entity is now called, may not be big enough, and so it may be only a matter of time before it gets swallowed. Warren’s overly broad proposal likely isn’t the answer. But Democrats do seem ready to at least try to rein in a market that’s gotten out of hand. For dealmakers, this may be last call at the M&A party.(1) Data compiled by Bloomberg as of Thursday morning. Excludes terminated deals.To contact the author of this story: Tara Lachapelle at tlachapelle@bloomberg.netTo contact the editor responsible for this story: Daniel Niemi at dniemi1@bloomberg.netThis column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.Tara Lachapelle is a Bloomberg Opinion columnist covering the business of entertainment and telecommunications, as well as broader deals. She previously wrote an M&A column for Bloomberg News.For more articles like this, please visit us at bloomberg.com/opinion©2019 Bloomberg L.P.
